Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million
— 10,000 participant randomized Phase 2b study will evaluate Gritstone’s self-amplifying mRNA (samRNA) vaccine candidate…
Fireflies Expands Beyond Meeting Intelligence and Launches Daily Briefs to Help People Prioritize Work Across Meetings, Email, and Slack